The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Transcervical Female Sterilization Market Research Report 2024
Synopsis
Transcervical tubal sterilization. Transcervical sterilization or tubal occlusion is a procedure that offers permanent birth control for women. It is a highly effective, minimally invasive alternative to surgical tubal ligation.
The global Transcervical Female Sterilization market was valued at US$ 715 million in 2023 and is anticipated to reach US$ 957.4 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Transcervical Female Sterilization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcervical Female Sterilization.
Report Scope
The Transcervical Female Sterilization market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcervical Female Sterilization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcervical Female Sterilization companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J & J
Medtronic
Karl Storz
Olympus
Applied Medical
Richard Wolf
Bayer AG
Stryker
B. Braun Aesculap
ERBE
LiNA Medical
ConMed
Microline Surgical
Apollo Endosurgery
Segment by Type
Tubal Ligation
Transcervical Implant
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcervical Female Sterilization companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Transcervical tubal sterilization. Transcervical sterilization or tubal occlusion is a procedure that offers permanent birth control for women. It is a highly effective, minimally invasive alternative to surgical tubal ligation.
The global Transcervical Female Sterilization market was valued at US$ 715 million in 2023 and is anticipated to reach US$ 957.4 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Transcervical Female Sterilization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcervical Female Sterilization.
Report Scope
The Transcervical Female Sterilization market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transcervical Female Sterilization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcervical Female Sterilization companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
J & J
Medtronic
Karl Storz
Olympus
Applied Medical
Richard Wolf
Bayer AG
Stryker
B. Braun Aesculap
ERBE
LiNA Medical
ConMed
Microline Surgical
Apollo Endosurgery
Segment by Type
Tubal Ligation
Transcervical Implant
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transcervical Female Sterilization companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transcervical Female Sterilization Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tubal Ligation
1.2.3 Transcervical Implant
1.3 Market by Application
1.3.1 Global Transcervical Female Sterilization Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcervical Female Sterilization Market Perspective (2019-2030)
2.2 Transcervical Female Sterilization Growth Trends by Region
2.2.1 Global Transcervical Female Sterilization Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transcervical Female Sterilization Historic Market Size by Region (2019-2024)
2.2.3 Transcervical Female Sterilization Forecasted Market Size by Region (2025-2030)
2.3 Transcervical Female Sterilization Market Dynamics
2.3.1 Transcervical Female Sterilization Industry Trends
2.3.2 Transcervical Female Sterilization Market Drivers
2.3.3 Transcervical Female Sterilization Market Challenges
2.3.4 Transcervical Female Sterilization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transcervical Female Sterilization Players by Revenue
3.1.1 Global Top Transcervical Female Sterilization Players by Revenue (2019-2024)
3.1.2 Global Transcervical Female Sterilization Revenue Market Share by Players (2019-2024)
3.2 Global Transcervical Female Sterilization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transcervical Female Sterilization Revenue
3.4 Global Transcervical Female Sterilization Market Concentration Ratio
3.4.1 Global Transcervical Female Sterilization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transcervical Female Sterilization Revenue in 2023
3.5 Transcervical Female Sterilization Key Players Head office and Area Served
3.6 Key Players Transcervical Female Sterilization Product Solution and Service
3.7 Date of Enter into Transcervical Female Sterilization Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transcervical Female Sterilization Breakdown Data by Type
4.1 Global Transcervical Female Sterilization Historic Market Size by Type (2019-2024)
4.2 Global Transcervical Female Sterilization Forecasted Market Size by Type (2025-2030)
5 Transcervical Female Sterilization Breakdown Data by Application
5.1 Global Transcervical Female Sterilization Historic Market Size by Application (2019-2024)
5.2 Global Transcervical Female Sterilization Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transcervical Female Sterilization Market Size (2019-2030)
6.2 North America Transcervical Female Sterilization Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transcervical Female Sterilization Market Size by Country (2019-2024)
6.4 North America Transcervical Female Sterilization Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transcervical Female Sterilization Market Size (2019-2030)
7.2 Europe Transcervical Female Sterilization Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transcervical Female Sterilization Market Size by Country (2019-2024)
7.4 Europe Transcervical Female Sterilization Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transcervical Female Sterilization Market Size (2019-2030)
8.2 Asia-Pacific Transcervical Female Sterilization Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transcervical Female Sterilization Market Size by Region (2019-2024)
8.4 Asia-Pacific Transcervical Female Sterilization Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transcervical Female Sterilization Market Size (2019-2030)
9.2 Latin America Transcervical Female Sterilization Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transcervical Female Sterilization Market Size by Country (2019-2024)
9.4 Latin America Transcervical Female Sterilization Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transcervical Female Sterilization Market Size (2019-2030)
10.2 Middle East & Africa Transcervical Female Sterilization Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transcervical Female Sterilization Market Size by Country (2019-2024)
10.4 Middle East & Africa Transcervical Female Sterilization Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 J & J
11.1.1 J & J Company Detail
11.1.2 J & J Business Overview
11.1.3 J & J Transcervical Female Sterilization Introduction
11.1.4 J & J Revenue in Transcervical Female Sterilization Business (2019-2024)
11.1.5 J & J Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Detail
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Transcervical Female Sterilization Introduction
11.2.4 Medtronic Revenue in Transcervical Female Sterilization Business (2019-2024)
11.2.5 Medtronic Recent Development
11.3 Karl Storz
11.3.1 Karl Storz Company Detail
11.3.2 Karl Storz Business Overview
11.3.3 Karl Storz Transcervical Female Sterilization Introduction
11.3.4 Karl Storz Revenue in Transcervical Female Sterilization Business (2019-2024)
11.3.5 Karl Storz Recent Development
11.4 Olympus
11.4.1 Olympus Company Detail
11.4.2 Olympus Business Overview
11.4.3 Olympus Transcervical Female Sterilization Introduction
11.4.4 Olympus Revenue in Transcervical Female Sterilization Business (2019-2024)
11.4.5 Olympus Recent Development
11.5 Applied Medical
11.5.1 Applied Medical Company Detail
11.5.2 Applied Medical Business Overview
11.5.3 Applied Medical Transcervical Female Sterilization Introduction
11.5.4 Applied Medical Revenue in Transcervical Female Sterilization Business (2019-2024)
11.5.5 Applied Medical Recent Development
11.6 Richard Wolf
11.6.1 Richard Wolf Company Detail
11.6.2 Richard Wolf Business Overview
11.6.3 Richard Wolf Transcervical Female Sterilization Introduction
11.6.4 Richard Wolf Revenue in Transcervical Female Sterilization Business (2019-2024)
11.6.5 Richard Wolf Recent Development
11.7 Bayer AG
11.7.1 Bayer AG Company Detail
11.7.2 Bayer AG Business Overview
11.7.3 Bayer AG Transcervical Female Sterilization Introduction
11.7.4 Bayer AG Revenue in Transcervical Female Sterilization Business (2019-2024)
11.7.5 Bayer AG Recent Development
11.8 Stryker
11.8.1 Stryker Company Detail
11.8.2 Stryker Business Overview
11.8.3 Stryker Transcervical Female Sterilization Introduction
11.8.4 Stryker Revenue in Transcervical Female Sterilization Business (2019-2024)
11.8.5 Stryker Recent Development
11.9 B. Braun Aesculap
11.9.1 B. Braun Aesculap Company Detail
11.9.2 B. Braun Aesculap Business Overview
11.9.3 B. Braun Aesculap Transcervical Female Sterilization Introduction
11.9.4 B. Braun Aesculap Revenue in Transcervical Female Sterilization Business (2019-2024)
11.9.5 B. Braun Aesculap Recent Development
11.10 ERBE
11.10.1 ERBE Company Detail
11.10.2 ERBE Business Overview
11.10.3 ERBE Transcervical Female Sterilization Introduction
11.10.4 ERBE Revenue in Transcervical Female Sterilization Business (2019-2024)
11.10.5 ERBE Recent Development
11.11 LiNA Medical
11.11.1 LiNA Medical Company Detail
11.11.2 LiNA Medical Business Overview
11.11.3 LiNA Medical Transcervical Female Sterilization Introduction
11.11.4 LiNA Medical Revenue in Transcervical Female Sterilization Business (2019-2024)
11.11.5 LiNA Medical Recent Development
11.12 ConMed
11.12.1 ConMed Company Detail
11.12.2 ConMed Business Overview
11.12.3 ConMed Transcervical Female Sterilization Introduction
11.12.4 ConMed Revenue in Transcervical Female Sterilization Business (2019-2024)
11.12.5 ConMed Recent Development
11.13 Microline Surgical
11.13.1 Microline Surgical Company Detail
11.13.2 Microline Surgical Business Overview
11.13.3 Microline Surgical Transcervical Female Sterilization Introduction
11.13.4 Microline Surgical Revenue in Transcervical Female Sterilization Business (2019-2024)
11.13.5 Microline Surgical Recent Development
11.14 Apollo Endosurgery
11.14.1 Apollo Endosurgery Company Detail
11.14.2 Apollo Endosurgery Business Overview
11.14.3 Apollo Endosurgery Transcervical Female Sterilization Introduction
11.14.4 Apollo Endosurgery Revenue in Transcervical Female Sterilization Business (2019-2024)
11.14.5 Apollo Endosurgery Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
